These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35270766)

  • 1. The Transmission, Infection Prevention, and Control during the COVID-19 Pandemic in China: A Retrospective Study.
    Zhang L; Welsch RE; Cao Z
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Population Emigration from Wuhan and Medical Support on COVID-19 Infection in China.
    Yao Y; Tian Y; Zhou J; Diao X; Di L; Wang S
    J Epidemiol Glob Health; 2021 Jun; 11(2):178-185. PubMed ID: 33605121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a bundle of intervention strategies for the control of COVID-19 in Henan, a neighboring province of Wuhan, China.
    Liu Q; Lu H; Chen R
    Wien Klin Wochenschr; 2020 Jul; 132(13-14):396-399. PubMed ID: 32548764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk estimation of the SARS-CoV-2 acute respiratory disease outbreak outside China.
    Kim S; Choi S; Ko Y; Ki M; Jung E
    Theor Biol Med Model; 2020 Jun; 17(1):9. PubMed ID: 32498721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
    Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will healthcare workers improve infection prevention and control behaviors as COVID-19 risk emerges and increases, in China?
    Lai X; Wang X; Yang Q; Xu X; Tang Y; Liu C; Tan L; Lai R; Wang H; Zhang X; Zhou Q; Chen H
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):83. PubMed ID: 32527300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the real number of infected people by COVID-19: A system dynamics approach.
    Hu B; Dehmer M; Emmert-Streib F; Zhang B
    PLoS One; 2021; 16(3):e0245728. PubMed ID: 33735225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China.
    Wei W; Zheng D; Lei Y; Wu S; Verma V; Liu Y; Wei X; Bi J; Hu D; Han G
    Radiother Oncol; 2020 Jul; 148():203-210. PubMed ID: 32342870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of China's Hubei control strategy for COVID-19 epidemic: an observational study.
    Liu Y; Zheng F; Du Z; Li J; Gu J; Jiang M; Yoneoka D; Gilmour S; Hao Y
    BMC Infect Dis; 2021 Aug; 21(1):820. PubMed ID: 34399697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cluster Transmission of Coronavirus Disease 2019 and the Prevention and Control Measures in the Early Stage of the Epidemic in Xi'an, China, 2020.
    Zhang H; Song S; Chen Z; Bai M; He Z; Fu T; Liu K; Shao Z
    Med Sci Monit; 2021 Jun; 27():e929701. PubMed ID: 34121087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of the COVID-19 epidemic and correlation with population emigration from Wuhan, China.
    Chen ZL; Zhang Q; Lu Y; Guo ZM; Zhang X; Zhang WJ; Guo C; Liao CH; Li QL; Han XH; Lu JH
    Chin Med J (Engl); 2020 May; 133(9):1044-1050. PubMed ID: 32118644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.
    Yin S; Peng Y; Ren Y; Hu M; Tang L; Xiang Z; Li X; Wang M; Wang W
    J Clin Virol; 2020 Jul; 128():104397. PubMed ID: 32388472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of household quarantine on SARS-Cov-2 infection in mainland China: A mean-field modelling approach.
    Yang JY; Wang GQ; Zhang S
    Math Biosci Eng; 2020 Jun; 17(5):4500-4512. PubMed ID: 33120515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of COVID-19 in Jiangxi, China: A retrospective observational study.
    Dong Y; Ding S; Zhang J; Liu Y
    Medicine (Baltimore); 2021 Oct; 100(43):e27685. PubMed ID: 34713866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mask crisis during the COVID-19 outbreak.
    Wang MW; Zhou MY; Ji GH; Ye L; Cheng YR; Feng ZH; Chen J
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3397-3399. PubMed ID: 32271457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policy disparities in response to the first wave of COVID-19 between China and Germany.
    Zhang Y; Shi L; Chen H; Wang X; Sun G
    Int J Equity Health; 2021 Mar; 20(1):86. PubMed ID: 33766049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological Investigation and Prevention Control Analysis of the Longitudinal Distribution of COVID-19 in Henan Province, China.
    Yang X; Chen X; Ding C; Bai Z; Zhu J; Sun G; Yu G
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33028688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatiotemporal distribution and trend of COVID-19 in the Yangtze River Delta region of the People's Republic of China.
    Ye L; Hu L
    Geospat Health; 2020 Jun; 15(1):. PubMed ID: 32575958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.